PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice

Eguren-Santamaria, I; Sanmamed, MF; Goldberg, SB; Kluger, HM; Idoate, MA; Lu, BY; Corral, J; Schalper, KA; Herbst, RS; Gil-Bazo, I

Gil-Bazo, I (corresponding author), Clin Univ Navarra, Pamplona 31008, Spain.

CLINICAL CANCER RESEARCH, 2020; 26 (16): 4186

Abstract

Immune checkpoint inhibitors (ICI) have revolutionized the management of advanced non-small cell lung cancer (NSCLC). However, most pivotal phase III ......

Full Text Link